There are 27 resources available
Introduction and Objectives
Presenter: T. S. K. Mok, HK, S. Peters, CH
Session: Welcome
Resources:
Slides
Webcast
Lung cancer screening: efficacy and cost-effectiveness
Presenter: L. Coate, IE
Session: SESSION 1 - Screening, diagnosis and staging
Resources:
Slides
Webcast
The role of pathology and genetic/molecular analyses
Presenter: L. Bubendorf, CH
Session: SESSION 1 - Screening, diagnosis and staging
Resources:
Slides
Webcast
Staging investigations at diagnosis
Presenter: G. Veronesi, IT
Session: SESSION 1 - Screening, diagnosis and staging
Resources:
Slides
Webcast
Adjuvant/Neo-adjuvant chemotherapy and radiotherapy strategies for resected NSCLC
Presenter: A-M. Dingemans, NL
Session: SESSION 2 - Adjuvant therapy
Resources:
Slides
Webcast
Adjuvant and neo-adjuvant targeted and immunotherapeutic agents: clinical evidence and clinical research
Presenter: D. S. W. Tan, SG
Session: SESSION 2 - Adjuvant therapy
Resources:
Slides
Webcast
Management of stage III - Case presentation- Surgeon/Radiotherapist/Medical oncologist’s point of view
Presenter: T. Mitsudomi, JP; K. Franks, UK; A-M. Dingemans, NL;
Session: SESSION 3 - Multi-disciplinary lung tumour board
Resources:
Slides
Webcast
Management of oligometastatic disease - Case presentation: Surgeon/Radiotherapist/Medical oncologist’s point of view
Presenter: T. Mitsudomi, JP; K. Franks, UK; T. S. K. Mok, HK;
Session: SESSION 4 - Multi-disciplinary lung tumour board
Resources:
Slides
Webcast
Participants clinical case discussion: A Case of Small Cell Transformation after second and third gen EGFR Targeted Therapy in Metastatic NSCLC
Presenter: D. Mondal, IN
Session: SESSION 5 - Audience cases
Resources:
Slides
Webcast
Participants clinical case discussion: EGFR exon 19 deletion in stage IIIB NSCLC: long-term response to neoadjuvant/adjuvant afatinib and first-line osimertinib
Presenter: P. Vlachosterigos, US
Session: SESSION 5 - Audience cases
Resources:
Slides
Webcast